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Abstract The aim of this study was to investigate possible
involvement of annexin XI in the insulin secretory machinery. In
fluorescence immunocytochemistry, annexin XI was found in the
cytoplasm of pancreatic endocrine cells and a pancreatic L-cell
line, MIN6, in a granular pattern. MIN6 cells also possessed
weak and diffused annexin XI immunoreactivity in the cyto-
plasm. Immunoelectron microscopy revealed annexin XI in the
insulin granules. Insulin secretion from streptolysin-O-permea-
bilized MIN6 cells was inhibited by anti-annexin XI antibody,
when the release was stimulated by either Ca2+ or GTP-QS, but
not by a protein kinase C-activating phorbol ester. Inhibition of
insulin release by anti-annexin XI antibody was reproduced in
permeabilized rat islets. These findings suggest that annexin XI
may be involved in the regulation of insulin secretion from the
pancreatic L-cells. ß 2000 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
Key words: Annexin; Insulin release; Ca2 ; GTP-QS;
Pancreatic L-cell
1. Introduction
Although it is widely accepted that an increase in intracel-
lular Ca2 concentrations is a crucial event in triggering hor-
mone secretion, we still have limited knowledge on relevant
intracellular Ca2 receptors. Many Ca2-binding proteins,
such as EF-hand proteins and annexins which have respective
Ca2-binding structures, the EF-hand domain and the core
domain, have been found in a variety of tissues or cells. These
proteins are considered to be responsible for transduction of
intracellular Ca2-signaling [1].
In the pancreatic L-cell, roles of intracellular Ca2 receptors
in insulin secretion are not fully understood except certain
proteins as calmodulin [2]. Annexins form a superfamily of
Ca2-binding proteins featured by Ca2-dependent phospho-
lipid-binding activities [3]. This property and preferential dis-
tribution of annexins in intracellular vesicles [4] suggest that
annexins may be involved in the membrane^membrane inter-
action and play positive roles in exocytosis, endocytosis, gran-
ule aggregation and the structural organization of membranes
[5^8] ; annexins I and III stimulate aggregation of the neutro-
phil granules and their fusion to the plasma membranes [9^
11]; some members of the annexin family are, in particular,
considered to participate in the control of exocytosis. For
example, annexin II is required in the secretory machinery
in chroma⁄n cells [12,13].
Annexin XI, initially designated as CAP-50 (calcyclin-asso-
ciated protein 50 kDa), was ¢rst puri¢ed from rabbit lung as a
protein which binds a two EF-hand Ca2-binding protein
calcyclin (or S100A6 [14]), in a speci¢c manner [15]. Annexin
XI is widely distributed in tissues and organs [16]. This an-
nexin is unique, because it possesses the longest N-terminal
domains, comprising of 197 amino acids, among all known
annexins. Annexin XI is expected to play versatile roles, be-
cause it is phosphorylated by a few protein kinases [17,18] and
because its long N-terminal domain includes the calcyclin-
binding site and proteolytic sites [19,20]. Nevertheless, we do
not know much on physiological functions of annexin XI.
In the present study, we investigated possible roles of an-
nexin XI in the regulation of insulin release by a morpholog-
ical approach and in the secretion study with a membrane
permeabilization technique using streptolysin-O (STLO).
2. Materials and methods
2.1. Materials
MIN6 cells were kindly donated by Prof. J.-I. Miyazaki (Osaka
University). 12-O-Tetradecanoylphorbol 13-acetate (TPA) was from
Wako (Tokyo, Japan). GTP-QS was from Sigma (St. Louis, MO,
USA). STLO was from Mullex Biotech (Dartford, UK). Dulbecco’s
modi¢ed Eagle medium (DMEM) was from Nissui (Tokyo, Japan).
Bovine serum albumin (BSA) (fraction V) was from Chemicon Inter-
national Inc. (Temecula, CA, USA). The insulin radioimmunoassay
kit was from Eiken (Tokyo, Japan). Rhodamine-conjugated goat anti-
guinea pig IgG was from ICN (Costa Mesa, USA). Guinea pig anti-
insulin antibody was from Seikagaku Kogyo (Tokyo, Japan). Fluo-
rescein isothianate (FITC)-conjugated goat anti-rabbit IgG was from
Vector (CA, USA). 10 nm gold colloidal particle-conjugated goat
anti-rabbit IgG and 15 nm gold colloidal particle-conjugated goat
anti-guinea pig IgG were from Amersham Japan (Tokyo, Japan).
Normal rabbit IgG was kindly provided by Dr. Y. Nishizawa (Na-
goya University). Anti-annexin XI serum was obtained in rabbits by
injecting annexin XI puri¢ed from bovine lung. This serum was spe-
ci¢c for annexin XI and did not crossreact with other annexins [16].
2.2. Cell culture
MIN6 cells (passages 32^39) were cultured in DMEM supple-
mented with 66 mg/l kanamycin sulfate and 15% fetal calf serum at
37‡C in a humidi¢ed atmosphere of 95% air/5% CO2 [21]. The cells
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were passaged and harvested using trypsin/EDTA and the culture
medium was replaced every other day.
2.3. Islet isolation
Pancreatic islets were isolated from male Wistar rats with collage-
nase digestion.
2.4. Fluorescence immunocytochemistry
Pancreases of the Wistar rats (male, 200 g body weight) or MIN6
cells grown on the cover glass were ¢xed with 2% paraformaldehyde
and 0.15% picric acid in 0.1 M phosphate bu¡er (PB, pH 7.4) for 1^4 h
at room temperature. After washing with phosphate-bu¡ered saline
(PBS, pH 7.2), pancreases were soaked overnight in 30% sucrose in
0.1 M PB at 4‡C, embedded in OCT compound and frozen quickly.
15 Wm thick sections were cut by a cryostat and mounted onto poly-L-
lysine-coated glass slides. Tissue sections on the slides and MIN6 cells
on the cover glass slips were treated with 0.3% Triton X-100 in PBS
for 30 min. They were immersed in 5% normal goat serum for 30 min,
and incubated with a mixture of anti-annexin XI serum and anti-
insulin serum overnight. After washing with PBS, specimens were
incubated with FITC-conjugated anti-rabbit IgG and rhodamine-con-
jugated anti-guinea pig IgG mixture for 1 h. After mounting with
PBS^glycerol containing paraphenilendiamine, cells were examined
with a confocal laser scanning microscope MRC-1024 (Bio-Rad) us-
ing a krypton^argon laser.
2.5. Immunoelectron microscopy
MIN6 cells were ¢xed with 2% paraformaldehyde, 0.15% picric acid
and 0.1% glutaraldehyde in 0.1 M PB for 1 h at room temperature.
After washing with PBS, cells were dehydrated in graded N,N-dime-
thylformamide at progressively lower temperatures and embedded in
Lowicryl K4M (TAAB) at 320‡C. Resin-embedded specimens were
cut with ultramicrotome and mounted on nickel grids. Ultrathin sec-
tions were treated with 2% BSA in PBS for 30 min and incubated with
a mixture of anti-annexin XI serum and anti-insulin serum for 4 h.
After washing with PBS, sections were incubated with 10 nm gold
colloidal particle-conjugated anti-rabbit IgG and 15 nm gold colloidal
particle-conjugated anti-guinea pig IgG mixture for 1 h. Sections were
Fig. 1. Distribution of annexin XI and insulin immunoreactivities in rat pancreatic islets and MIN6 cells. 15 Wm thick sections of the rat pan-
creas or MIN6 cells were double-stained with anti-annexin XI (A and D) and anti-insulin (B and E) antibodies, and examined with confocal la-
ser scanning microscopy. A, B and C: Double-stained images of the rat pancreatic islet. Annexin XI-immunopositive granular structures (ar-
rows in A) were mostly positive for insulin immunoreactivity (arrows in B) and shown in yellow in double-stained images (arrows in C). Note
that there are some insulin granules without annexin XI immunoreactivity and that the nuclei (N) were never stained with anti-annexin XI anti-
body. D, E and F: MIN6 cells contained annexin XI immunoreactivity in the insulin granules and cytoplasm (C). Arrows show double-stained
granules. Some cells showed di¡used distribution of annexin XI in the peripheral cytoplasm (arrowheads in D). Bars = 10 Wm.
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counterstained with uranyl acetate and lead citrate, and examined
with a Hitachi H-7100 electron microscope.
2.6. Secretion study with permeabilized cells
MIN6 cells were seeded at a density of 2U104 cells per well into a
48-MultiWell (Sumitomo, Tokyo, Japan) 2^3 days prior to an experi-
ment. On the day of experimentation, MIN6 cells were preincubated
for 1 h at 37‡C in 0.5 ml of HEPES^Krebs bu¡er (20 mM HEPES,
117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2
mM KH2PO4, 5.0 mM NaHCO3, pH = 7.4) supplemented with 5 mg/
ml BSA. After washing twice with 0.5 ml of the glutamate bu¡er
containing (mM): K-glutamate 100, Na-glutamate 42, HEPES (pH
7.0) 16, MgATP 3, EGTA 1 and 5 mg/ml BSA with 10 nM Ca2,
the cells were further incubated for 30 min in 0.5 ml of the glutamate
bu¡er at 10 nM to 10 WM Ca2 plus 250 U/l STLO and various
substances and anti-annexin XI antibody. CaCl2 was added to the
glutamate bu¡er to give an arbitrary concentration of free Ca2,
and we veri¢ed the free Ca2 concentration by a Ca2-£uorescent
dye. At the end of the 30 min incubation, the medium was spun
brie£y to sediment any detached cells, and the supernatant was re-
tained for insulin assay. For islet secretion study, groups of size-
matched ¢ve isolated islets were preincubated for 1 h in BSA-contain-
ing HEPES^Krebs bu¡er with 3 mM glucose. Islets were, then,
washed twice with basal glutamate bu¡er (Ca2 0.1 WM) and further
incubated for the glutamate bu¡er supplemented with various sub-
stances and 250 U/l STLO. After 1 h incubation, insulin released
into the media was assayed by radioimmunoassay.
3. Results
3.1. Fluorescence immunocytochemistry
In rat pancreatic islets, numerous cells contained annexin
XI immunoreactivity (Fig. 1A^C). Some of islet cells pos-
sessed annexin XI-immunopositive granular structures. It
must be noted that none of the nuclei exhibited annexin XI
immunoreactivity (N, in Fig. 1A^C). Double staining with
anti-annexin XI and anti-insulin antibodies revealed preferen-
tial distribution of annexin XI in the insulin granules (Fig.
1C). Annexin XI immunoreactivity, also distributed in gluca-
gon- or somatostatin-immunopositive cells (not shown), was
restricted to the pancreatic islet cells and was not observed in
pancreatic acinar cells and ¢broblasts (not shown). Intracel-
lular distribution of annexin XI was also examined in the
insulin-secreting cell line MIN6 (Fig. 1D^F). Annexin XI im-
munoreactivity in the cytoplasm exhibited a granular or a
di¡used pattern (Fig. 1D). Most of annexin XI-immunopos-
itive granular structures in MIN6 cells showed insulin immu-
noreactivity (Fig. 1F). The immunoreactivity disappeared
when anti-annexin XI antibody was pre-absorbed with excess
of the antigen.
3.2. Immunoelectron microscopy
To verify co-localization of annexin XI and insulin, we
carried out immunoelectron microscopy of MIN6 cells. As
shown in Fig. 2, MIN6 cells possessed electron dense large
granules which showed insulin immunoreactivity (15 nm gold
particles). 10 nm gold particles representing annexin XI im-
munoreactivity were accumulated in these granules. Annexin
XI immunoreactivity was also distributed in the cytoplasm
although this reaction was weaker. In MIN6 cells, nuclei
and other organelles were, as in islet cells, free from the im-
munoreactivity.
3.3. Insulin secretion from permeabilized MIN6 cells and rat
pancreatic islets
Fig. 3 depicts e¡ects of anti-annexin XI antibody on insulin
secretion permeabilized with STLO. Inhibition of Ca2-in-
duced insulin release by anti-annexin XI antibody is demon-
strated in Fig. 3A. In permeabilized MIN6 cells, a signi¢cant
increase in insulin release was observed with Ca2 at concen-
trations higher than 10 nM. This threshold for Ca2 to initiate
insulin release agrees to other reports using pancreatic islets or
L-cell lines with other permeabilization techniques [22,23].
Anti-annexin XI antibody (U250) inhibited insulin release
with 10 WM Ca2 (38.5% inhibition of stimulated release)
without a¡ecting those at lower concentrations of Ca2.
This is compatible with general properties of annexin-binding
to cell membranes; half maximal binding of annexins IV, VI
or VII to cell membranes requires Ca2 within a low WM
range [24]. We also investigated the e¡ects of annexin XI anti-
body on insulin release from permeabilized MIN6 cells by
GTP-QS and the protein kinase C (PKC) activator TPA,
Fig. 2. Immunoelectron micrographs of MIN6 cells with anti-annexin XI and anti-insulin antibodies. Ultrathin sections of resin-embedded
MIN6 cells were double-stained with the immunogold method and observed with electron microscopy. Some of insulin-immunoreactive (large
dense particles) granules contained annexin XI immunoreactivity (small dense particles, arrows). Annexin XI immunoreactivity also distributed
in the cytoplasm (arrowheads). Asterisks show cell membranes. Bars = 1 nm.
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both of which induce insulin release independently of changes
in intracellular Ca2 [23,25]. GTP-QS (100 WM) and TPA (200
nM) increased insulin release from permeabilized MIN6 cells,
and addition of anti-annexin XI antibody decreased only the
former by 48.8% (Fig. 3B).
Inhibition of Ca2-induced insulin release by anti-annexin
XI antibody was more pronounced in STLO-permeabilized
islets (3.09 þ 0.23 vs. 0.58 þ 0.12 ng/¢ve islets/h for 10 WM
Ca2 and 10 WM Ca2 plus anti-annexin XI antibody, respec-
tively, n = 5, P6 0.001). GTP-QS (100 WM)-induced insulin
release from permeabilized islets was also inhibited by anti-
annexin XI antibody (2.93 þ 0.17 vs. 1.96 þ 0.05 ng/¢ve islets/h
for 100 WM GTP-QS and GTP-QS plus anti-annexin XI anti-
body, respectively, n = 5, P6 0.01). TPA-induced insulin
release was, as in MIN6 cells, not a¡ected by anti-annexin
XI antibody (1.91 þ 0.1 vs. 1.59 þ 0.11 ng/¢ve islets/h for
200 nM TPA and TPA plus anti-annexin XI antibody, re-
spectively, n = 5, n.s.). Normal rabbit IgG (up to 32 Wg/ml)
failed to decrease insulin release by Ca2 or GTP-QS (not
shown).
4. Discussion
In the L-cells, annexins I and II have also been demon-
strated to exist in islet cells in the rat pancreas [26]. Annexin
I is distributed on the insulin granule membranes, and its
phosphorylation was shown to be increased by glucose [27].
It has been suggested that annexin I may participate in the
regulation of glucose-induced insulin release via protein phos-
phorylation, because glucose-induced serine phosphorylation
of annexin I was inhibited by a PKC inhibitor H-7, which also
suppressed insulin release. However, there is as yet no direct
evidence available on the in£uences of annexins on the secre-
tory machinery of the pancreatic L-cell.
The present ¢ndings suggest to us that annexin XI may be
involved in the regulation of insulin release. It is, however,
unlikely that its PKC activation is necessary for annexin XI-
dependent regulation of insulin release, because (i) anti-annex-
in XI antibody failed to a¡ect TPA-induced insulin release
and (ii) annexin XI was, in our attempts, not phosphorylated
by PKC in vitro (T. Sudo, unpublished data). Inhibition of
Ca2- and GTP-QS-dependent insulin release by anti-annexin
XI antibody reminds us of a previous report that both Ca2-
and GTP-QS-induced membrane fusion of chroma⁄n granules
was accelerated by addition of synexin (annexin VII) [28],
suggesting similar roles of annexins VII and XI in the chro-
ma⁄n cell and the pancreatic L-cell, respectively. Possible
regulation of annexin functions by nucleotides including
GTP has recently been reviewed [29].
It is interesting that certain EF-hand proteins and annexins
interact with each other in a speci¢c manner and may exert
their roles. The S100-binding sites of some annexins show
similar hydrophobic residue clusters [19,30]. Annexins I and
XI have respective Ca2-dependent binding activities to cal-
gizzarin (S100C) and calcyclin (S100A6) [15,19,31,32], while
binding of annexin II to p11 (S100A10) does not require Ca2
[33]. Binding of p11 to annexin II plays an important role in
catecholamine release via regulating intracellular distribution
of the annexin [13], and a similar role has also been suggested
in artery endothelial cells [34]. We previously reported that
calcyclin may play a positive role in insulin release [22].
Although further direct evidence is necessary, the annexin
XI/calcyclin complex may function in insulin secretion in a
co-operative manner. In conclusion, the present ¢ndings
strongly indicate that annexin XI is involved in the secretory
processes in the L-cells.
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